Navigation Links
Stroke risk reduced if brain blood vessel disorder is left alone
Date:4/29/2014

Treating patients who suffer from a common condition that affects blood vessels in the brain increases their risk of stroke, a study has found.

People with a condition known as arteriovenous malformation (AVM) which causes blood vessels in the brain to tangle have a better outcome if doctors treat their symptoms only and not the AVM.

A team of doctors looked at the long-term outcome of patients with the condition, which is caused by abnormal connections between the arteries and veins in the brain.

They found that, over a 12 year period, patients who chose not to be treated for their condition were less likely to have a stroke or die from related causes. These patients were also less likely to suffer sustained disability compared with those who opted for an intervention to treat the tangles.

This is the first study to compare the risks and benefits of treatment for AVM in the long term. The findings build on previous research that reported an increased risk of stroke in the first three years after treatment for AVM.

AVM affects around 1 in 2000 people. Although most people with the condition can lead relatively normal lives, they live with the risk that the tangles can burst and bleed into the brain at any time, causing a stroke. Around one in every hundred AVM patients suffers a stroke each year.

In some cases doctors can surgically remove the tangle or block the blood vessels involved to reduce the risk of bleeding. However, treatment can sometimes increase the chances that the tangle will burst and bleed into the brain, resulting in a stroke.

Professor Rustam Al-Shahi Salman, MRC Senior Clinical Fellow at the University of Edinburgh and a consultant neurologist, said: "Many patients feel that living with AVM is like living with a time bomb in your head that could explode at any time. Patients and their doctors face difficult choices when deciding whether or not to pursue treatment. We have found that, for most people whose AVM has not caused a bleed, the risks of treatment exceed the risks of leaving it alone over 12 years."


'/>"/>

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. Airport security-style technology could help doctors decide on stroke treatment
2. $8 million NIH grant will fund multicenter clinical trial of stroke intervention drug
3. Study IDs new cause of brain bleeding immediately after stroke
4. Study links severe sleep apnea to increased risk of stroke, cancer and death
5. Surgery after major stroke also improves survival odds in elderly patients
6. Drinking alcohol several times a week increases the risk of stroke mortality
7. Stroke patients may benefit from new routines
8. Halting immune response could save brain cells after stroke
9. New stroke research combines brain stimulation, gait training
10. Stroke in children will be focus of $3 million grant
11. MU study suggests new rehabilitation methods for amputees and stroke patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology: